nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonorgestrel—ESR1—coronary artery disease	0.238	1	CbGaD
Levonorgestrel—Testosterone Propionate—Eplerenone—coronary artery disease	0.073	0.215	CrCrCtD
Levonorgestrel—Progesterone—Eplerenone—coronary artery disease	0.073	0.215	CrCrCtD
Levonorgestrel—Methyltestosterone—Eplerenone—coronary artery disease	0.0712	0.209	CrCrCtD
Levonorgestrel—Testosterone—Eplerenone—coronary artery disease	0.0634	0.186	CrCrCtD
Levonorgestrel—Hydrocortisone—Eplerenone—coronary artery disease	0.0595	0.175	CrCrCtD
Levonorgestrel—CYP3A4—Ticagrelor—coronary artery disease	0.0226	0.146	CbGbCtD
Levonorgestrel—CYP3A4—Fenofibrate—coronary artery disease	0.0201	0.13	CbGbCtD
Levonorgestrel—CYP3A4—Gemfibrozil—coronary artery disease	0.0161	0.104	CbGbCtD
Levonorgestrel—CYP3A4—Clopidogrel—coronary artery disease	0.0139	0.0905	CbGbCtD
Levonorgestrel—CYP3A4—Eplerenone—coronary artery disease	0.013	0.0841	CbGbCtD
Levonorgestrel—CYP3A4—Enalapril—coronary artery disease	0.0116	0.075	CbGbCtD
Levonorgestrel—CYP3A4—Ezetimibe—coronary artery disease	0.00899	0.0583	CbGbCtD
Levonorgestrel—CYP3A4—Rosuvastatin—coronary artery disease	0.00899	0.0583	CbGbCtD
Levonorgestrel—CYP3A4—Simvastatin—coronary artery disease	0.00836	0.0542	CbGbCtD
Levonorgestrel—CYP3A4—Pravastatin—coronary artery disease	0.00818	0.053	CbGbCtD
Levonorgestrel—CYP3A4—Lovastatin—coronary artery disease	0.00818	0.053	CbGbCtD
Levonorgestrel—CYP3A4—Atorvastatin—coronary artery disease	0.00745	0.0483	CbGbCtD
Levonorgestrel—CYP3A4—Losartan—coronary artery disease	0.00681	0.0442	CbGbCtD
Levonorgestrel—Hydrocortisone—CYP11B2—coronary artery disease	0.000324	0.0899	CrCbGaD
Levonorgestrel—Danazol—CCL2—coronary artery disease	0.000322	0.0893	CrCbGaD
Levonorgestrel—Quinestrol—ESR1—coronary artery disease	0.000317	0.088	CrCbGaD
Levonorgestrel—Ethynodiol—ESR1—coronary artery disease	0.000261	0.0725	CrCbGaD
Levonorgestrel—Allylestrenol—ESR1—coronary artery disease	0.000247	0.0684	CrCbGaD
Levonorgestrel—Mestranol—ESR1—coronary artery disease	0.00024	0.0667	CrCbGaD
Levonorgestrel—Desogestrel—ESR1—coronary artery disease	0.000237	0.0659	CrCbGaD
Levonorgestrel—Norgestimate—ESR1—coronary artery disease	0.000222	0.0616	CrCbGaD
Levonorgestrel—Etonogestrel—ESR1—coronary artery disease	0.000192	0.0533	CrCbGaD
Levonorgestrel—Progesterone—NR3C2—coronary artery disease	0.000187	0.052	CrCbGaD
Levonorgestrel—Ethinyl Estradiol—ESR2—coronary artery disease	0.000186	0.0516	CrCbGaD
Levonorgestrel—Progesterone—SLC22A3—coronary artery disease	0.000131	0.0363	CrCbGaD
Levonorgestrel—Danazol—ESR1—coronary artery disease	0.000124	0.0343	CrCbGaD
Levonorgestrel—Testosterone—SLC22A3—coronary artery disease	0.000124	0.0343	CrCbGaD
Levonorgestrel—Ethinyl Estradiol—ESR1—coronary artery disease	0.000115	0.0318	CrCbGaD
Levonorgestrel—Norethindrone—CYP2C19—coronary artery disease	8.84e-05	0.0245	CrCbGaD
Levonorgestrel—Progesterone—ESR1—coronary artery disease	6.42e-05	0.0178	CrCbGaD
Levonorgestrel—Rash—Lovastatin—coronary artery disease	5.58e-05	0.000311	CcSEcCtD
Levonorgestrel—Dermatitis—Lovastatin—coronary artery disease	5.57e-05	0.00031	CcSEcCtD
Levonorgestrel—Anaemia—Lisinopril—coronary artery disease	5.57e-05	0.00031	CcSEcCtD
Levonorgestrel—Dyspepsia—Losartan—coronary artery disease	5.56e-05	0.00031	CcSEcCtD
Levonorgestrel—Headache—Lovastatin—coronary artery disease	5.54e-05	0.000309	CcSEcCtD
Levonorgestrel—Pruritus—Valsartan—coronary artery disease	5.53e-05	0.000308	CcSEcCtD
Levonorgestrel—Chest pain—Timolol—coronary artery disease	5.53e-05	0.000308	CcSEcCtD
Levonorgestrel—Myalgia—Timolol—coronary artery disease	5.53e-05	0.000308	CcSEcCtD
Levonorgestrel—Vomiting—Ezetimibe—coronary artery disease	5.52e-05	0.000307	CcSEcCtD
Levonorgestrel—Hypersensitivity—Pravastatin—coronary artery disease	5.51e-05	0.000307	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Perindopril—coronary artery disease	5.51e-05	0.000307	CcSEcCtD
Levonorgestrel—Anxiety—Timolol—coronary artery disease	5.51e-05	0.000307	CcSEcCtD
Levonorgestrel—Angioedema—Lisinopril—coronary artery disease	5.5e-05	0.000306	CcSEcCtD
Levonorgestrel—Pruritus—Olmesartan—coronary artery disease	5.5e-05	0.000306	CcSEcCtD
Levonorgestrel—Decreased appetite—Losartan—coronary artery disease	5.49e-05	0.000306	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	5.49e-05	0.000306	CcSEcCtD
Levonorgestrel—Abdominal pain—Captopril—coronary artery disease	5.49e-05	0.000305	CcSEcCtD
Levonorgestrel—Body temperature increased—Captopril—coronary artery disease	5.49e-05	0.000305	CcSEcCtD
Levonorgestrel—Dizziness—Simvastatin—coronary artery disease	5.47e-05	0.000305	CcSEcCtD
Levonorgestrel—Rash—Ezetimibe—coronary artery disease	5.47e-05	0.000305	CcSEcCtD
Levonorgestrel—Dermatitis—Ezetimibe—coronary artery disease	5.47e-05	0.000304	CcSEcCtD
Levonorgestrel—Discomfort—Timolol—coronary artery disease	5.46e-05	0.000304	CcSEcCtD
Levonorgestrel—Asthenia—Niacin—coronary artery disease	5.45e-05	0.000303	CcSEcCtD
Levonorgestrel—Fatigue—Losartan—coronary artery disease	5.45e-05	0.000303	CcSEcCtD
Levonorgestrel—Headache—Ezetimibe—coronary artery disease	5.44e-05	0.000303	CcSEcCtD
Levonorgestrel—Oedema—Ramipril—coronary artery disease	5.42e-05	0.000302	CcSEcCtD
Levonorgestrel—Vertigo—Lisinopril—coronary artery disease	5.41e-05	0.000301	CcSEcCtD
Levonorgestrel—Pain—Losartan—coronary artery disease	5.4e-05	0.000301	CcSEcCtD
Levonorgestrel—Constipation—Losartan—coronary artery disease	5.4e-05	0.000301	CcSEcCtD
Levonorgestrel—Syncope—Lisinopril—coronary artery disease	5.4e-05	0.000301	CcSEcCtD
Levonorgestrel—Vomiting—Eplerenone—coronary artery disease	5.4e-05	0.000301	CcSEcCtD
Levonorgestrel—Nausea—Fenofibrate—coronary artery disease	5.38e-05	0.0003	CcSEcCtD
Levonorgestrel—Pruritus—Niacin—coronary artery disease	5.38e-05	0.000299	CcSEcCtD
Levonorgestrel—Asthenia—Pravastatin—coronary artery disease	5.37e-05	0.000299	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Furosemide—coronary artery disease	5.36e-05	0.000298	CcSEcCtD
Levonorgestrel—Rash—Eplerenone—coronary artery disease	5.35e-05	0.000298	CcSEcCtD
Levonorgestrel—Urticaria—Perindopril—coronary artery disease	5.35e-05	0.000298	CcSEcCtD
Levonorgestrel—Hypersensitivity—Trandolapril—coronary artery disease	5.35e-05	0.000298	CcSEcCtD
Levonorgestrel—Dermatitis—Eplerenone—coronary artery disease	5.35e-05	0.000298	CcSEcCtD
Levonorgestrel—Diarrhoea—Valsartan—coronary artery disease	5.35e-05	0.000298	CcSEcCtD
Levonorgestrel—Shock—Ramipril—coronary artery disease	5.33e-05	0.000297	CcSEcCtD
Levonorgestrel—Hypersensitivity—Enalapril—coronary artery disease	5.33e-05	0.000297	CcSEcCtD
Levonorgestrel—Body temperature increased—Perindopril—coronary artery disease	5.33e-05	0.000297	CcSEcCtD
Levonorgestrel—Abdominal pain—Perindopril—coronary artery disease	5.33e-05	0.000297	CcSEcCtD
Levonorgestrel—Palpitations—Lisinopril—coronary artery disease	5.32e-05	0.000296	CcSEcCtD
Levonorgestrel—Diarrhoea—Olmesartan—coronary artery disease	5.32e-05	0.000296	CcSEcCtD
Levonorgestrel—Headache—Eplerenone—coronary artery disease	5.32e-05	0.000296	CcSEcCtD
Levonorgestrel—Nervous system disorder—Ramipril—coronary artery disease	5.31e-05	0.000296	CcSEcCtD
Levonorgestrel—Oedema—Timolol—coronary artery disease	5.3e-05	0.000295	CcSEcCtD
Levonorgestrel—Pruritus—Pravastatin—coronary artery disease	5.29e-05	0.000295	CcSEcCtD
Levonorgestrel—Loss of consciousness—Lisinopril—coronary artery disease	5.29e-05	0.000295	CcSEcCtD
Levonorgestrel—Nausea—Clopidogrel—coronary artery disease	5.29e-05	0.000294	CcSEcCtD
Levonorgestrel—Skin disorder—Ramipril—coronary artery disease	5.26e-05	0.000293	CcSEcCtD
Levonorgestrel—Infection—Timolol—coronary artery disease	5.26e-05	0.000293	CcSEcCtD
Levonorgestrel—Vomiting—Simvastatin—coronary artery disease	5.26e-05	0.000293	CcSEcCtD
Levonorgestrel—Hypersensitivity—Telmisartan—coronary artery disease	5.26e-05	0.000293	CcSEcCtD
Levonorgestrel—Cough—Lisinopril—coronary artery disease	5.25e-05	0.000293	CcSEcCtD
Levonorgestrel—Nausea—Lovastatin—coronary artery disease	5.25e-05	0.000293	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Ramipril—coronary artery disease	5.24e-05	0.000292	CcSEcCtD
Levonorgestrel—Rash—Simvastatin—coronary artery disease	5.22e-05	0.00029	CcSEcCtD
Levonorgestrel—Dermatitis—Simvastatin—coronary artery disease	5.21e-05	0.00029	CcSEcCtD
Levonorgestrel—Asthenia—Trandolapril—coronary artery disease	5.21e-05	0.00029	CcSEcCtD
Levonorgestrel—Shock—Timolol—coronary artery disease	5.21e-05	0.00029	CcSEcCtD
Levonorgestrel—Urticaria—Furosemide—coronary artery disease	5.2e-05	0.00029	CcSEcCtD
Levonorgestrel—Diarrhoea—Niacin—coronary artery disease	5.2e-05	0.000289	CcSEcCtD
Levonorgestrel—Nervous system disorder—Timolol—coronary artery disease	5.2e-05	0.000289	CcSEcCtD
Levonorgestrel—Asthenia—Enalapril—coronary artery disease	5.19e-05	0.000289	CcSEcCtD
Levonorgestrel—Headache—Simvastatin—coronary artery disease	5.18e-05	0.000289	CcSEcCtD
Levonorgestrel—Abdominal pain—Furosemide—coronary artery disease	5.18e-05	0.000288	CcSEcCtD
Levonorgestrel—Body temperature increased—Furosemide—coronary artery disease	5.18e-05	0.000288	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Losartan—coronary artery disease	5.17e-05	0.000288	CcSEcCtD
Levonorgestrel—Dizziness—Valsartan—coronary artery disease	5.17e-05	0.000288	CcSEcCtD
Levonorgestrel—Anorexia—Ramipril—coronary artery disease	5.17e-05	0.000288	CcSEcCtD
Levonorgestrel—Nausea—Ezetimibe—coronary artery disease	5.15e-05	0.000287	CcSEcCtD
Levonorgestrel—Progesterone—CYP2C19—coronary artery disease	5.15e-05	0.0143	CrCbGaD
Levonorgestrel—Skin disorder—Timolol—coronary artery disease	5.15e-05	0.000286	CcSEcCtD
Levonorgestrel—Dizziness—Olmesartan—coronary artery disease	5.14e-05	0.000286	CcSEcCtD
Levonorgestrel—Pruritus—Trandolapril—coronary artery disease	5.14e-05	0.000286	CcSEcCtD
Levonorgestrel—Chest pain—Lisinopril—coronary artery disease	5.13e-05	0.000285	CcSEcCtD
Levonorgestrel—Myalgia—Lisinopril—coronary artery disease	5.13e-05	0.000285	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Timolol—coronary artery disease	5.12e-05	0.000285	CcSEcCtD
Levonorgestrel—Asthenia—Telmisartan—coronary artery disease	5.12e-05	0.000285	CcSEcCtD
Levonorgestrel—Pruritus—Enalapril—coronary artery disease	5.12e-05	0.000285	CcSEcCtD
Levonorgestrel—Diarrhoea—Pravastatin—coronary artery disease	5.12e-05	0.000285	CcSEcCtD
Levonorgestrel—Anxiety—Lisinopril—coronary artery disease	5.11e-05	0.000284	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	5.09e-05	0.000283	CcSEcCtD
Levonorgestrel—Discomfort—Lisinopril—coronary artery disease	5.07e-05	0.000282	CcSEcCtD
Levonorgestrel—Anorexia—Timolol—coronary artery disease	5.05e-05	0.000281	CcSEcCtD
Levonorgestrel—Pruritus—Telmisartan—coronary artery disease	5.05e-05	0.000281	CcSEcCtD
Levonorgestrel—Nausea—Eplerenone—coronary artery disease	5.04e-05	0.000281	CcSEcCtD
Levonorgestrel—Dizziness—Niacin—coronary artery disease	5.02e-05	0.00028	CcSEcCtD
Levonorgestrel—Urticaria—Losartan—coronary artery disease	5.02e-05	0.00028	CcSEcCtD
Levonorgestrel—Abdominal pain—Losartan—coronary artery disease	5e-05	0.000278	CcSEcCtD
Levonorgestrel—Body temperature increased—Losartan—coronary artery disease	5e-05	0.000278	CcSEcCtD
Levonorgestrel—Asthenia—Captopril—coronary artery disease	4.98e-05	0.000277	CcSEcCtD
Levonorgestrel—Diarrhoea—Trandolapril—coronary artery disease	4.97e-05	0.000277	CcSEcCtD
Levonorgestrel—Vomiting—Valsartan—coronary artery disease	4.97e-05	0.000277	CcSEcCtD
Levonorgestrel—Diarrhoea—Enalapril—coronary artery disease	4.95e-05	0.000276	CcSEcCtD
Levonorgestrel—Dizziness—Pravastatin—coronary artery disease	4.95e-05	0.000275	CcSEcCtD
Levonorgestrel—Vomiting—Olmesartan—coronary artery disease	4.94e-05	0.000275	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Ramipril—coronary artery disease	4.94e-05	0.000275	CcSEcCtD
Levonorgestrel—Rash—Valsartan—coronary artery disease	4.93e-05	0.000274	CcSEcCtD
Levonorgestrel—Dermatitis—Valsartan—coronary artery disease	4.92e-05	0.000274	CcSEcCtD
Levonorgestrel—Nausea—Simvastatin—coronary artery disease	4.91e-05	0.000274	CcSEcCtD
Levonorgestrel—Oedema—Lisinopril—coronary artery disease	4.91e-05	0.000274	CcSEcCtD
Levonorgestrel—Pruritus—Captopril—coronary artery disease	4.91e-05	0.000273	CcSEcCtD
Levonorgestrel—Norethindrone—ALB—coronary artery disease	4.91e-05	0.0136	CrCbGaD
Levonorgestrel—Rash—Olmesartan—coronary artery disease	4.9e-05	0.000273	CcSEcCtD
Levonorgestrel—Insomnia—Ramipril—coronary artery disease	4.9e-05	0.000273	CcSEcCtD
Levonorgestrel—Dermatitis—Olmesartan—coronary artery disease	4.9e-05	0.000273	CcSEcCtD
Levonorgestrel—Headache—Valsartan—coronary artery disease	4.9e-05	0.000273	CcSEcCtD
Levonorgestrel—Diarrhoea—Telmisartan—coronary artery disease	4.88e-05	0.000272	CcSEcCtD
Levonorgestrel—Infection—Lisinopril—coronary artery disease	4.88e-05	0.000272	CcSEcCtD
Levonorgestrel—Headache—Olmesartan—coronary artery disease	4.87e-05	0.000271	CcSEcCtD
Levonorgestrel—Testosterone—CYP2C19—coronary artery disease	4.87e-05	0.0135	CrCbGaD
Levonorgestrel—Shock—Lisinopril—coronary artery disease	4.83e-05	0.000269	CcSEcCtD
Levonorgestrel—Asthenia—Perindopril—coronary artery disease	4.83e-05	0.000269	CcSEcCtD
Levonorgestrel—Dyspnoea—Ramipril—coronary artery disease	4.83e-05	0.000269	CcSEcCtD
Levonorgestrel—Vomiting—Niacin—coronary artery disease	4.83e-05	0.000269	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Timolol—coronary artery disease	4.83e-05	0.000269	CcSEcCtD
Levonorgestrel—Hypersensitivity—Furosemide—coronary artery disease	4.83e-05	0.000269	CcSEcCtD
Levonorgestrel—Somnolence—Ramipril—coronary artery disease	4.82e-05	0.000268	CcSEcCtD
Levonorgestrel—Dizziness—Trandolapril—coronary artery disease	4.8e-05	0.000267	CcSEcCtD
Levonorgestrel—Insomnia—Timolol—coronary artery disease	4.79e-05	0.000267	CcSEcCtD
Levonorgestrel—Rash—Niacin—coronary artery disease	4.79e-05	0.000267	CcSEcCtD
Levonorgestrel—Dermatitis—Niacin—coronary artery disease	4.79e-05	0.000266	CcSEcCtD
Levonorgestrel—Dizziness—Enalapril—coronary artery disease	4.78e-05	0.000266	CcSEcCtD
Levonorgestrel—Skin disorder—Lisinopril—coronary artery disease	4.77e-05	0.000266	CcSEcCtD
Levonorgestrel—Dyspepsia—Ramipril—coronary artery disease	4.77e-05	0.000266	CcSEcCtD
Levonorgestrel—Pruritus—Perindopril—coronary artery disease	4.77e-05	0.000265	CcSEcCtD
Levonorgestrel—Headache—Niacin—coronary artery disease	4.76e-05	0.000265	CcSEcCtD
Levonorgestrel—Vomiting—Pravastatin—coronary artery disease	4.76e-05	0.000265	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Lisinopril—coronary artery disease	4.75e-05	0.000264	CcSEcCtD
Levonorgestrel—Diarrhoea—Captopril—coronary artery disease	4.75e-05	0.000264	CcSEcCtD
Levonorgestrel—Dyspnoea—Timolol—coronary artery disease	4.72e-05	0.000263	CcSEcCtD
Levonorgestrel—Dizziness—Telmisartan—coronary artery disease	4.72e-05	0.000263	CcSEcCtD
Levonorgestrel—Rash—Pravastatin—coronary artery disease	4.72e-05	0.000263	CcSEcCtD
Levonorgestrel—Dermatitis—Pravastatin—coronary artery disease	4.71e-05	0.000262	CcSEcCtD
Levonorgestrel—Decreased appetite—Ramipril—coronary artery disease	4.71e-05	0.000262	CcSEcCtD
Levonorgestrel—Somnolence—Timolol—coronary artery disease	4.71e-05	0.000262	CcSEcCtD
Levonorgestrel—Asthenia—Furosemide—coronary artery disease	4.7e-05	0.000262	CcSEcCtD
Levonorgestrel—Headache—Pravastatin—coronary artery disease	4.69e-05	0.000261	CcSEcCtD
Levonorgestrel—Anorexia—Lisinopril—coronary artery disease	4.68e-05	0.000261	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Ramipril—coronary artery disease	4.68e-05	0.00026	CcSEcCtD
Levonorgestrel—Fatigue—Ramipril—coronary artery disease	4.67e-05	0.00026	CcSEcCtD
Levonorgestrel—Dyspepsia—Timolol—coronary artery disease	4.66e-05	0.00026	CcSEcCtD
Levonorgestrel—Methyltestosterone—ALB—coronary artery disease	4.66e-05	0.0129	CrCbGaD
Levonorgestrel—Hypersensitivity—Losartan—coronary artery disease	4.66e-05	0.000259	CcSEcCtD
Levonorgestrel—Nausea—Valsartan—coronary artery disease	4.64e-05	0.000258	CcSEcCtD
Levonorgestrel—Pruritus—Furosemide—coronary artery disease	4.63e-05	0.000258	CcSEcCtD
Levonorgestrel—Constipation—Ramipril—coronary artery disease	4.63e-05	0.000258	CcSEcCtD
Levonorgestrel—Nausea—Olmesartan—coronary artery disease	4.62e-05	0.000257	CcSEcCtD
Levonorgestrel—Vomiting—Trandolapril—coronary artery disease	4.62e-05	0.000257	CcSEcCtD
Levonorgestrel—Diarrhoea—Perindopril—coronary artery disease	4.61e-05	0.000257	CcSEcCtD
Levonorgestrel—Decreased appetite—Timolol—coronary artery disease	4.61e-05	0.000256	CcSEcCtD
Levonorgestrel—Vomiting—Enalapril—coronary artery disease	4.6e-05	0.000256	CcSEcCtD
Levonorgestrel—Dizziness—Captopril—coronary artery disease	4.59e-05	0.000255	CcSEcCtD
Levonorgestrel—Rash—Trandolapril—coronary artery disease	4.58e-05	0.000255	CcSEcCtD
Levonorgestrel—Dermatitis—Trandolapril—coronary artery disease	4.58e-05	0.000255	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Timolol—coronary artery disease	4.57e-05	0.000255	CcSEcCtD
Levonorgestrel—Fatigue—Timolol—coronary artery disease	4.57e-05	0.000254	CcSEcCtD
Levonorgestrel—Rash—Enalapril—coronary artery disease	4.56e-05	0.000254	CcSEcCtD
Levonorgestrel—Dermatitis—Enalapril—coronary artery disease	4.56e-05	0.000254	CcSEcCtD
Levonorgestrel—Headache—Trandolapril—coronary artery disease	4.55e-05	0.000253	CcSEcCtD
Levonorgestrel—Vomiting—Telmisartan—coronary artery disease	4.54e-05	0.000253	CcSEcCtD
Levonorgestrel—Asthenia—Losartan—coronary artery disease	4.53e-05	0.000252	CcSEcCtD
Levonorgestrel—Headache—Enalapril—coronary artery disease	4.53e-05	0.000252	CcSEcCtD
Levonorgestrel—Pain—Timolol—coronary artery disease	4.53e-05	0.000252	CcSEcCtD
Levonorgestrel—Nausea—Niacin—coronary artery disease	4.51e-05	0.000251	CcSEcCtD
Levonorgestrel—Rash—Telmisartan—coronary artery disease	4.5e-05	0.000251	CcSEcCtD
Levonorgestrel—Dermatitis—Telmisartan—coronary artery disease	4.5e-05	0.00025	CcSEcCtD
Levonorgestrel—Diarrhoea—Furosemide—coronary artery disease	4.48e-05	0.000249	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Lisinopril—coronary artery disease	4.48e-05	0.000249	CcSEcCtD
Levonorgestrel—Pruritus—Losartan—coronary artery disease	4.47e-05	0.000249	CcSEcCtD
Levonorgestrel—Headache—Telmisartan—coronary artery disease	4.47e-05	0.000249	CcSEcCtD
Levonorgestrel—Dizziness—Perindopril—coronary artery disease	4.46e-05	0.000248	CcSEcCtD
Levonorgestrel—Insomnia—Lisinopril—coronary artery disease	4.44e-05	0.000247	CcSEcCtD
Levonorgestrel—Nausea—Pravastatin—coronary artery disease	4.44e-05	0.000247	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Ramipril—coronary artery disease	4.43e-05	0.000247	CcSEcCtD
Levonorgestrel—Vomiting—Captopril—coronary artery disease	4.41e-05	0.000246	CcSEcCtD
Levonorgestrel—Dyspnoea—Lisinopril—coronary artery disease	4.38e-05	0.000244	CcSEcCtD
Levonorgestrel—Rash—Captopril—coronary artery disease	4.38e-05	0.000244	CcSEcCtD
Levonorgestrel—Dermatitis—Captopril—coronary artery disease	4.37e-05	0.000243	CcSEcCtD
Levonorgestrel—Somnolence—Lisinopril—coronary artery disease	4.37e-05	0.000243	CcSEcCtD
Levonorgestrel—Headache—Captopril—coronary artery disease	4.35e-05	0.000242	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Timolol—coronary artery disease	4.33e-05	0.000241	CcSEcCtD
Levonorgestrel—Dizziness—Furosemide—coronary artery disease	4.33e-05	0.000241	CcSEcCtD
Levonorgestrel—Dyspepsia—Lisinopril—coronary artery disease	4.33e-05	0.000241	CcSEcCtD
Levonorgestrel—Diarrhoea—Losartan—coronary artery disease	4.32e-05	0.000241	CcSEcCtD
Levonorgestrel—Nausea—Trandolapril—coronary artery disease	4.31e-05	0.00024	CcSEcCtD
Levonorgestrel—Urticaria—Ramipril—coronary artery disease	4.3e-05	0.00024	CcSEcCtD
Levonorgestrel—Nausea—Enalapril—coronary artery disease	4.3e-05	0.000239	CcSEcCtD
Levonorgestrel—Vomiting—Perindopril—coronary artery disease	4.28e-05	0.000238	CcSEcCtD
Levonorgestrel—Abdominal pain—Ramipril—coronary artery disease	4.28e-05	0.000238	CcSEcCtD
Levonorgestrel—Body temperature increased—Ramipril—coronary artery disease	4.28e-05	0.000238	CcSEcCtD
Levonorgestrel—Decreased appetite—Lisinopril—coronary artery disease	4.27e-05	0.000238	CcSEcCtD
Levonorgestrel—Rash—Perindopril—coronary artery disease	4.25e-05	0.000237	CcSEcCtD
Levonorgestrel—Dermatitis—Perindopril—coronary artery disease	4.24e-05	0.000236	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Lisinopril—coronary artery disease	4.24e-05	0.000236	CcSEcCtD
Levonorgestrel—Nausea—Telmisartan—coronary artery disease	4.24e-05	0.000236	CcSEcCtD
Levonorgestrel—Fatigue—Lisinopril—coronary artery disease	4.24e-05	0.000236	CcSEcCtD
Levonorgestrel—Headache—Perindopril—coronary artery disease	4.22e-05	0.000235	CcSEcCtD
Levonorgestrel—Urticaria—Timolol—coronary artery disease	4.21e-05	0.000234	CcSEcCtD
Levonorgestrel—Pain—Lisinopril—coronary artery disease	4.2e-05	0.000234	CcSEcCtD
Levonorgestrel—Constipation—Lisinopril—coronary artery disease	4.2e-05	0.000234	CcSEcCtD
Levonorgestrel—Abdominal pain—Timolol—coronary artery disease	4.19e-05	0.000233	CcSEcCtD
Levonorgestrel—Body temperature increased—Timolol—coronary artery disease	4.19e-05	0.000233	CcSEcCtD
Levonorgestrel—Dizziness—Losartan—coronary artery disease	4.18e-05	0.000233	CcSEcCtD
Levonorgestrel—Vomiting—Furosemide—coronary artery disease	4.16e-05	0.000232	CcSEcCtD
Levonorgestrel—Rash—Furosemide—coronary artery disease	4.13e-05	0.00023	CcSEcCtD
Levonorgestrel—Dermatitis—Furosemide—coronary artery disease	4.13e-05	0.00023	CcSEcCtD
Levonorgestrel—Nausea—Captopril—coronary artery disease	4.12e-05	0.000229	CcSEcCtD
Levonorgestrel—Headache—Furosemide—coronary artery disease	4.1e-05	0.000228	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Lisinopril—coronary artery disease	4.02e-05	0.000224	CcSEcCtD
Levonorgestrel—Vomiting—Losartan—coronary artery disease	4.02e-05	0.000224	CcSEcCtD
Levonorgestrel—Nausea—Perindopril—coronary artery disease	4e-05	0.000223	CcSEcCtD
Levonorgestrel—Hypersensitivity—Ramipril—coronary artery disease	3.99e-05	0.000222	CcSEcCtD
Levonorgestrel—Rash—Losartan—coronary artery disease	3.98e-05	0.000222	CcSEcCtD
Levonorgestrel—Dermatitis—Losartan—coronary artery disease	3.98e-05	0.000222	CcSEcCtD
Levonorgestrel—Headache—Losartan—coronary artery disease	3.96e-05	0.00022	CcSEcCtD
Levonorgestrel—Urticaria—Lisinopril—coronary artery disease	3.9e-05	0.000217	CcSEcCtD
Levonorgestrel—Hypersensitivity—Timolol—coronary artery disease	3.9e-05	0.000217	CcSEcCtD
Levonorgestrel—Nausea—Furosemide—coronary artery disease	3.89e-05	0.000217	CcSEcCtD
Levonorgestrel—Asthenia—Ramipril—coronary artery disease	3.89e-05	0.000216	CcSEcCtD
Levonorgestrel—Abdominal pain—Lisinopril—coronary artery disease	3.88e-05	0.000216	CcSEcCtD
Levonorgestrel—Body temperature increased—Lisinopril—coronary artery disease	3.88e-05	0.000216	CcSEcCtD
Levonorgestrel—Pruritus—Ramipril—coronary artery disease	3.83e-05	0.000213	CcSEcCtD
Levonorgestrel—Asthenia—Timolol—coronary artery disease	3.8e-05	0.000212	CcSEcCtD
Levonorgestrel—Nausea—Losartan—coronary artery disease	3.75e-05	0.000209	CcSEcCtD
Levonorgestrel—Pruritus—Timolol—coronary artery disease	3.75e-05	0.000209	CcSEcCtD
Levonorgestrel—Diarrhoea—Ramipril—coronary artery disease	3.71e-05	0.000206	CcSEcCtD
Levonorgestrel—Diarrhoea—Timolol—coronary artery disease	3.62e-05	0.000202	CcSEcCtD
Levonorgestrel—Hypersensitivity—Lisinopril—coronary artery disease	3.62e-05	0.000202	CcSEcCtD
Levonorgestrel—Dizziness—Ramipril—coronary artery disease	3.58e-05	0.000199	CcSEcCtD
Levonorgestrel—Asthenia—Lisinopril—coronary artery disease	3.53e-05	0.000196	CcSEcCtD
Levonorgestrel—Dizziness—Timolol—coronary artery disease	3.5e-05	0.000195	CcSEcCtD
Levonorgestrel—Pruritus—Lisinopril—coronary artery disease	3.48e-05	0.000194	CcSEcCtD
Levonorgestrel—Vomiting—Ramipril—coronary artery disease	3.45e-05	0.000192	CcSEcCtD
Levonorgestrel—Rash—Ramipril—coronary artery disease	3.42e-05	0.00019	CcSEcCtD
Levonorgestrel—Dermatitis—Ramipril—coronary artery disease	3.41e-05	0.00019	CcSEcCtD
Levonorgestrel—Headache—Ramipril—coronary artery disease	3.39e-05	0.000189	CcSEcCtD
Levonorgestrel—Vomiting—Timolol—coronary artery disease	3.37e-05	0.000188	CcSEcCtD
Levonorgestrel—Diarrhoea—Lisinopril—coronary artery disease	3.36e-05	0.000187	CcSEcCtD
Levonorgestrel—Rash—Timolol—coronary artery disease	3.34e-05	0.000186	CcSEcCtD
Levonorgestrel—Dermatitis—Timolol—coronary artery disease	3.34e-05	0.000186	CcSEcCtD
Levonorgestrel—Headache—Timolol—coronary artery disease	3.32e-05	0.000185	CcSEcCtD
Levonorgestrel—Dizziness—Lisinopril—coronary artery disease	3.25e-05	0.000181	CcSEcCtD
Levonorgestrel—Nausea—Ramipril—coronary artery disease	3.22e-05	0.000179	CcSEcCtD
Levonorgestrel—Nausea—Timolol—coronary artery disease	3.15e-05	0.000175	CcSEcCtD
Levonorgestrel—Vomiting—Lisinopril—coronary artery disease	3.12e-05	0.000174	CcSEcCtD
Levonorgestrel—Rash—Lisinopril—coronary artery disease	3.1e-05	0.000173	CcSEcCtD
Levonorgestrel—Dermatitis—Lisinopril—coronary artery disease	3.1e-05	0.000172	CcSEcCtD
Levonorgestrel—Headache—Lisinopril—coronary artery disease	3.08e-05	0.000171	CcSEcCtD
Levonorgestrel—Nausea—Lisinopril—coronary artery disease	2.92e-05	0.000163	CcSEcCtD
Levonorgestrel—Testosterone—ALB—coronary artery disease	2.7e-05	0.00749	CrCbGaD
Levonorgestrel—PGR—Signaling Pathways—ITGB3—coronary artery disease	8.47e-06	0.0001	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—POMC—coronary artery disease	8.45e-06	9.99e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SH2B3—coronary artery disease	8.44e-06	9.97e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—VWF—coronary artery disease	8.44e-06	9.97e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ATP2A2—coronary artery disease	8.44e-06	9.97e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—SIRT1—coronary artery disease	8.42e-06	9.94e-05	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—MAPK14—coronary artery disease	8.39e-06	9.91e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—APOC3—coronary artery disease	8.39e-06	9.91e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—LDLR—coronary artery disease	8.34e-06	9.85e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PPP2CA—coronary artery disease	8.23e-06	9.72e-05	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—ESR1—coronary artery disease	8.23e-06	9.72e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CXCL2—coronary artery disease	8.14e-06	9.62e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCL3—coronary artery disease	8.14e-06	9.62e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PRKCD—coronary artery disease	8.08e-06	9.55e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SDC1—coronary artery disease	8.05e-06	9.51e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—F2R—coronary artery disease	8.05e-06	9.51e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HTR2A—coronary artery disease	7.91e-06	9.35e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—C3—coronary artery disease	7.9e-06	9.33e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FGB—coronary artery disease	7.88e-06	9.31e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—EDNRB—coronary artery disease	7.8e-06	9.21e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—THBS1—coronary artery disease	7.68e-06	9.07e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GSTP1—coronary artery disease	7.63e-06	9.01e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PSMB5—coronary artery disease	7.61e-06	8.98e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PSMA6—coronary artery disease	7.61e-06	8.98e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GYG1—coronary artery disease	7.56e-06	8.93e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PFKM—coronary artery disease	7.56e-06	8.93e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—LDHA—coronary artery disease	7.56e-06	8.93e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GK—coronary artery disease	7.56e-06	8.93e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HMGCS2—coronary artery disease	7.56e-06	8.93e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GATM—coronary artery disease	7.56e-06	8.93e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PPARGC1A—coronary artery disease	7.56e-06	8.93e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HIF1A—coronary artery disease	7.53e-06	8.9e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—HMOX1—coronary artery disease	7.52e-06	8.88e-05	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—PPARG—coronary artery disease	7.51e-06	8.87e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AGT—coronary artery disease	7.51e-06	8.87e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—PPP2CA—coronary artery disease	7.43e-06	8.78e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CAT—coronary artery disease	7.42e-06	8.77e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—EDNRA—coronary artery disease	7.36e-06	8.7e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—APOE—coronary artery disease	7.35e-06	8.69e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—LEP—coronary artery disease	7.35e-06	8.69e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ADRB1—coronary artery disease	7.33e-06	8.66e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CYBA—coronary artery disease	7.33e-06	8.66e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—DUSP6—coronary artery disease	7.3e-06	8.62e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—PRKCD—coronary artery disease	7.3e-06	8.62e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—APOA1—coronary artery disease	7.27e-06	8.59e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—AK1—coronary artery disease	7.21e-06	8.52e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GCH1—coronary artery disease	7.21e-06	8.52e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—KDR—coronary artery disease	7.21e-06	8.51e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—APOB—coronary artery disease	7.2e-06	8.51e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PLAT—coronary artery disease	7.18e-06	8.48e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MAPK14—coronary artery disease	7.16e-06	8.46e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ESR1—coronary artery disease	7.02e-06	8.29e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GSTM1—coronary artery disease	7.01e-06	8.28e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—FN1—coronary artery disease	6.94e-06	8.19e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—F2—coronary artery disease	6.94e-06	8.19e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CXCL12—coronary artery disease	6.92e-06	8.18e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—BDKRB2—coronary artery disease	6.92e-06	8.18e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PPAT—coronary artery disease	6.91e-06	8.17e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—MDH2—coronary artery disease	6.91e-06	8.17e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—UGCG—coronary artery disease	6.91e-06	8.17e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PLCD1—coronary artery disease	6.91e-06	8.17e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IL6ST—coronary artery disease	6.91e-06	8.16e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—LPL—coronary artery disease	6.88e-06	8.13e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NFKBIA—coronary artery disease	6.85e-06	8.1e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—JUNB—coronary artery disease	6.79e-06	8.03e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PLCB1—coronary artery disease	6.77e-06	8e-05	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—SERPINE1—coronary artery disease	6.76e-06	7.99e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GPX1—coronary artery disease	6.71e-06	7.93e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PGM1—coronary artery disease	6.65e-06	7.86e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—KIT—coronary artery disease	6.64e-06	7.84e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HTR7—coronary artery disease	6.63e-06	7.83e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CD36—coronary artery disease	6.54e-06	7.72e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—MAPK14—coronary artery disease	6.46e-06	7.63e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PPP2CA—coronary artery disease	6.45e-06	7.62e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PYGB—coronary artery disease	6.43e-06	7.59e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CKB—coronary artery disease	6.43e-06	7.59e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—GSK3B—coronary artery disease	6.37e-06	7.52e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—POMC—coronary artery disease	6.32e-06	7.46e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CREB1—coronary artery disease	6.32e-06	7.46e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ITGAV—coronary artery disease	6.32e-06	7.46e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—KNG1—coronary artery disease	6.3e-06	7.44e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AGTR1—coronary artery disease	6.26e-06	7.4e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—MTHFR—coronary artery disease	6.19e-06	7.32e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CCL2—coronary artery disease	6.18e-06	7.3e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IL6R—coronary artery disease	6.16e-06	7.28e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CXCL10—coronary artery disease	6.12e-06	7.23e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PLG—coronary artery disease	6.1e-06	7.21e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IGF1—coronary artery disease	6.08e-06	7.18e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—DLAT—coronary artery disease	6.04e-06	7.14e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PFKFB3—coronary artery disease	6.04e-06	7.14e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTM2—coronary artery disease	6.04e-06	7.14e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—COX5B—coronary artery disease	6.04e-06	7.14e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PLIN1—coronary artery disease	6.04e-06	7.14e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ADRB2—coronary artery disease	5.94e-06	7.02e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—AGT—coronary artery disease	5.88e-06	6.95e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PRKCE—coronary artery disease	5.86e-06	6.93e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SOCS1—coronary artery disease	5.85e-06	6.91e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—S100B—coronary artery disease	5.83e-06	6.89e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—PPARG—coronary artery disease	5.78e-06	6.83e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SOCS3—coronary artery disease	5.78e-06	6.82e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—SERPINE1—coronary artery disease	5.77e-06	6.82e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—APOE—coronary artery disease	5.77e-06	6.81e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SULT1E1—coronary artery disease	5.73e-06	6.77e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—KITLG—coronary artery disease	5.71e-06	6.74e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TGFBR2—coronary artery disease	5.71e-06	6.74e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—APOA1—coronary artery disease	5.7e-06	6.73e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—FGF2—coronary artery disease	5.59e-06	6.6e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—STAT5A—coronary artery disease	5.58e-06	6.59e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MMP3—coronary artery disease	5.58e-06	6.59e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NOS3—coronary artery disease	5.51e-06	6.51e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—AKR1B1—coronary artery disease	5.46e-06	6.45e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HK2—coronary artery disease	5.46e-06	6.45e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	5.46e-06	6.45e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—APOB—coronary artery disease	5.39e-06	6.37e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—JAK2—coronary artery disease	5.35e-06	6.33e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—EDN1—coronary artery disease	5.31e-06	6.27e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCL5—coronary artery disease	5.27e-06	6.22e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SLC27A1—coronary artery disease	5.24e-06	6.19e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—SERPINE1—coronary artery disease	5.21e-06	6.15e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CSF2—coronary artery disease	5.19e-06	6.13e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FGF1—coronary artery disease	5.19e-06	6.13e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—LPL—coronary artery disease	5.15e-06	6.08e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CPT1B—coronary artery disease	5.14e-06	6.07e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—LCAT—coronary artery disease	5.14e-06	6.07e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—RPS6KB1—coronary artery disease	5.1e-06	6.03e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MEF2C—coronary artery disease	5.1e-06	6.03e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—APOA4—coronary artery disease	5.04e-06	5.96e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PPARG—coronary artery disease	5.02e-06	5.93e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ITGB3—coronary artery disease	4.97e-06	5.87e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—POMC—coronary artery disease	4.95e-06	5.85e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CXCL8—coronary artery disease	4.89e-06	5.77e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PDHA1—coronary artery disease	4.87e-06	5.75e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GCLM—coronary artery disease	4.87e-06	5.75e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PPP2CA—coronary artery disease	4.83e-06	5.71e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PRKCD—coronary artery disease	4.74e-06	5.6e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP11B2—coronary artery disease	4.72e-06	5.57e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—TXNRD1—coronary artery disease	4.72e-06	5.57e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CASP3—coronary artery disease	4.68e-06	5.53e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SLC22A3—coronary artery disease	4.65e-06	5.49e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HTR2A—coronary artery disease	4.64e-06	5.48e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—C3—coronary artery disease	4.64e-06	5.48e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ARNTL—coronary artery disease	4.58e-06	5.41e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HADH—coronary artery disease	4.58e-06	5.41e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CCND1—coronary artery disease	4.55e-06	5.38e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ALB—coronary artery disease	4.52e-06	5.33e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HIF1A—coronary artery disease	4.42e-06	5.22e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MMP9—coronary artery disease	4.42e-06	5.22e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AGT—coronary artery disease	4.41e-06	5.2e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	4.34e-06	5.13e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GPX2—coronary artery disease	4.34e-06	5.13e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—APOA2—coronary artery disease	4.34e-06	5.13e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—NOS3—coronary artery disease	4.32e-06	5.1e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—LEP—coronary artery disease	4.32e-06	5.1e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—APOE—coronary artery disease	4.32e-06	5.1e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SULT1A1—coronary artery disease	4.29e-06	5.06e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GPX4—coronary artery disease	4.29e-06	5.06e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ABCG5—coronary artery disease	4.29e-06	5.06e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HK1—coronary artery disease	4.29e-06	5.06e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—APOA1—coronary artery disease	4.27e-06	5.04e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HADHA—coronary artery disease	4.24e-06	5e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—KDR—coronary artery disease	4.23e-06	5e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MAPK14—coronary artery disease	4.2e-06	4.96e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTA1—coronary artery disease	4.19e-06	4.95e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—LPA—coronary artery disease	4.14e-06	4.89e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FN1—coronary artery disease	4.07e-06	4.81e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—F2—coronary artery disease	4.07e-06	4.81e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IL6ST—coronary artery disease	4.05e-06	4.79e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NFKBIA—coronary artery disease	4.02e-06	4.75e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PLCB3—coronary artery disease	4.01e-06	4.74e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—APOA5—coronary artery disease	3.97e-06	4.69e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—VEGFA—coronary artery disease	3.97e-06	4.69e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PTGS2—coronary artery disease	3.95e-06	4.67e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—KIT—coronary artery disease	3.9e-06	4.6e-05	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—AKT1—coronary artery disease	3.9e-06	4.6e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—P4HB—coronary artery disease	3.89e-06	4.6e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	3.82e-06	4.51e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GSK3B—coronary artery disease	3.74e-06	4.42e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—POMC—coronary artery disease	3.71e-06	4.38e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CREB1—coronary artery disease	3.71e-06	4.38e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TGFB1—coronary artery disease	3.64e-06	4.3e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCL2—coronary artery disease	3.63e-06	4.29e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IL6R—coronary artery disease	3.62e-06	4.27e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—VCAN—coronary artery disease	3.6e-06	4.26e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ALDOA—coronary artery disease	3.57e-06	4.22e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MAPK1—coronary artery disease	3.57e-06	4.22e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IGF1—coronary artery disease	3.57e-06	4.21e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—DCN—coronary artery disease	3.47e-06	4.1e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SERPINE1—coronary artery disease	3.39e-06	4e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ALDH2—coronary artery disease	3.38e-06	3.99e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP2C19—coronary artery disease	3.29e-06	3.89e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	3.29e-06	3.89e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HBA1—coronary artery disease	3.29e-06	3.89e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—LIPC—coronary artery disease	3.29e-06	3.89e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FGF2—coronary artery disease	3.28e-06	3.87e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—APOC3—coronary artery disease	3.27e-06	3.86e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—LDLR—coronary artery disease	3.25e-06	3.84e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NOS3—coronary artery disease	3.23e-06	3.82e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTT1—coronary artery disease	3.21e-06	3.79e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SLC9A1—coronary artery disease	3.21e-06	3.79e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GCLC—coronary artery disease	3.17e-06	3.75e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CETP—coronary artery disease	3.17e-06	3.75e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—JAK2—coronary artery disease	3.14e-06	3.71e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SDC1—coronary artery disease	3.14e-06	3.71e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PIK3CA—coronary artery disease	3.1e-06	3.66e-05	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—AKT1—coronary artery disease	2.97e-06	3.51e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.96e-06	3.5e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.96e-06	3.5e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CTGF—coronary artery disease	2.9e-06	3.42e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HMGCR—coronary artery disease	2.87e-06	3.39e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GOT2—coronary artery disease	2.87e-06	3.39e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CXCL8—coronary artery disease	2.87e-06	3.39e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CASP3—coronary artery disease	2.75e-06	3.24e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IL6—coronary artery disease	2.75e-06	3.24e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCND1—coronary artery disease	2.67e-06	3.16e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.64e-06	3.12e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MMP9—coronary artery disease	2.59e-06	3.06e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.56e-06	3.02e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AKT1—coronary artery disease	2.53e-06	2.99e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GOT1—coronary artery disease	2.48e-06	2.93e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GGT1—coronary artery disease	2.48e-06	2.93e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PIK3CA—coronary artery disease	2.43e-06	2.87e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—VEGFA—coronary artery disease	2.33e-06	2.75e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—AKT1—coronary artery disease	2.29e-06	2.7e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.23e-06	2.63e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.2e-06	2.6e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.19e-06	2.59e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CAT—coronary artery disease	2.17e-06	2.56e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TGFB1—coronary artery disease	2.14e-06	2.53e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—APOB—coronary artery disease	2.1e-06	2.48e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MAPK1—coronary artery disease	2.1e-06	2.48e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTM1—coronary artery disease	2.05e-06	2.42e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—LPL—coronary artery disease	2.01e-06	2.37e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—AKT1—coronary artery disease	1.99e-06	2.35e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GPX1—coronary artery disease	1.96e-06	2.31e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CD36—coronary artery disease	1.91e-06	2.25e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.88e-06	2.23e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PIK3CA—coronary artery disease	1.82e-06	2.15e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.81e-06	2.14e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—AGT—coronary artery disease	1.72e-06	2.03e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—APOE—coronary artery disease	1.68e-06	1.99e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—APOA1—coronary artery disease	1.66e-06	1.96e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IL6—coronary artery disease	1.61e-06	1.9e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AKT1—coronary artery disease	1.49e-06	1.76e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PPARG—coronary artery disease	1.47e-06	1.73e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—POMC—coronary artery disease	1.45e-06	1.71e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ALB—coronary artery disease	1.32e-06	1.56e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NOS3—coronary artery disease	1.26e-06	1.49e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.15e-06	1.36e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PIK3CA—coronary artery disease	7.09e-07	8.38e-06	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—AKT1—coronary artery disease	5.79e-07	6.85e-06	CbGpPWpGaD
